Vertex Pharmaceuticals cystic fibrosis royalties
GPTKB entity
Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:royalty_stream
|
| gptkbp:buyIn |
gptkb:Royalty_Pharma
|
| gptkbp:includes |
royalties from Kalydeco
royalties from Orkambi royalties from Symdeko royalties from Trikafta |
| gptkbp:notableTransaction |
Cystic Fibrosis Foundation sold royalty rights in 2014
|
| gptkbp:recipient |
gptkb:Cystic_Fibrosis_Foundation
|
| gptkbp:relatedTo |
gptkb:Vertex_Pharmaceuticals
cystic fibrosis treatments |
| gptkbp:source |
sales of cystic fibrosis drugs
|
| gptkbp:transactionValue |
$3.3 billion
|
| gptkbp:transactionYear |
2014
|
| gptkbp:bfsParent |
gptkb:Royalty_Pharma
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vertex Pharmaceuticals cystic fibrosis royalties
|